Lactobacillus acidophilus and Clostridium butyricum ameliorate colitis in murine by strengthening the gut barrier function and decreasing inflammatory factors

Beneficial Microbes
Y WangH Wang

Abstract

Ulcerative colitis is a type of chronic inflammation present in the intestines for which the aetiology is not yet clear. The current therapies for ulcerative colitis cannot be considered to be long-term management strategies due to their significant side effects. Therefore, it is essential to identify an alternative therapeutic strategy for ulcerative colitis. The present study focused on the evaluation of the anti-inflammatory activities of Lactobacillus acidophilus CGMCC 7282 and Clostridium butyricum CGMCC 7281. The roles of both single and combination of L. acidophilus CGMCC 7282 and C. butyricum CGMCC 7281 in ulcerative colitis were investigated in 2,4,6-trinitrobenzenesulfonic acid-induced acute colitis (Th1-type colitis) in Sprague-Dawley rats and oxazolone-induced chronic colitis (Th2-type colitis) in BALB/c mice. The in vivo studies showed that the administration of L. acidophilus CGMCC 7282, C. butyricum CGMCC 7281 and L. acidophilus CGMCC 7282 plus C. butyricum CGMCC 7281 could reduce the Th1-type colitis as well as the Th2-type colitis, and the combination of the two strains exhibited the most notable effects, as indicated by the reduced mortality rates, the suppressed disease activity indices, the improved body wei...Continue Reading

References

Nov 1, 1995·The Journal of Experimental Medicine·M F NeurathW Strober
Apr 14, 1999·The American Journal of Gastroenterology·P KarlénP G Persson
Aug 29, 2000·Inflammatory Bowel Diseases·C Jobin, R B Sartor
Jan 10, 2002·Clinical Microbiology Reviews·Barbara A HendricksonJudy H Cho
Aug 31, 2004·The Journal of Nutrition·Rosa L DiazMartín G Martín
Sep 30, 2004·International Journal of Food Microbiology·H M TimmermanA C Beynen
Apr 5, 2007·Nature Protocols·Stefan WirtzMarkus F Neurath
Aug 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Daniel N FrankNorman R Pace
Sep 11, 2007·Advanced Drug Delivery Reviews·Stefan Wirtz, Markus F Neurath
Oct 2, 2007·Current Opinion in Gastroenterology·Monica Boirivant, Warren Strober
Jul 16, 2008·Inflammatory Bowel Diseases·Charles VanderpoolD Brent Polk
Jun 19, 2009·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G MoorthyS Niranjali Devaraj
Jul 28, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ajit SoodRakesh K Tandon
Jun 22, 2010·Inflammatory Bowel Diseases·Joshua M UronisChristian Jobin
Apr 6, 2011·Gut·Craig MowatUNKNOWN IBD Section of the British Society of Gastroenterology
Apr 13, 2011·Current Opinion in Gastroenterology·Lulu SunThaddeus S Stappenbeck
Jun 17, 2011·Nature·Bernard KhorRamnik J Xavier
Dec 25, 2012·Gut·Venessa EeckhautFilip Van Immerseel
Sep 12, 2013·Journal of Translational Medicine·Walter E CromerJ Michael Mathis
Nov 26, 2013·Gastroenterology·Kerstin GronbachJulia-Stefanie Frick
Nov 18, 2014·World Journal of Gastroenterology : WJG·Wei-Xu ChenRui-Hua Shi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here